Children with 21-OHD need chronic cGC therapy as soon as they are diagnosed with the disease in order to reduce excessive ACTH and consequent increase androgen production, by substituting for deficient cortisol and when necessary mineralocorticoid synthesis [15]. This evidence concerns the gene POMC and classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.